Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Biliary Tract Neoplasms × tislelizumab × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Liver Diseases 1 Hypersensitivity 1 Biliary Tract Neoplasms 1 Advanced Colorectal Carcinoma 1

Interventions

Liquid Biopsy 4 Blood Specimen Collection 4 Gemcitabine 3 pembrolizumab 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 Base Sequence 2 130-nm albumin-bound paclitaxel 2 tislelizumab 1 taxane 1 lenvatinib 1 irinotecan sucrosofate 1 Tegafur 1 Taxes 1 Standard of Care 1 S 1 (combination) 1 Polymerase Chain Reaction 1 Platinum Compounds 1 Oxaliplatin 1 Nivolumab 1 Microscopy, Confocal 1 Methylation 1 Mass Spectrometry 1 Leucovorin 1 Irinotecan 1 High-Throughput Nucleotide Sequencing 1 Gene Expression Profiling 1 Folfox protocol 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06893380 2025-09-15

GENTIS

CHA University

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡